The AcrySof IQ PanOptix trifocal IOL delivers a full range of good uncorrected vision, leads to high rates of patient satisfaction, and simplifies surgical counseling and planning.
This article was reviewed by Cathleen M. McCabe, MD
In August, the FDA granted approval for Alcon to market the AcrySof IQ PanOptix trifocal IOL. Surgeons who are using the lens, which is available in spherical and toric versions, agree that it is an important advance in presbyopia-correcting technology.
Cathleen M. McCabe, MD, chief medical officer, Eye Health America, and medical director, The Eye Associates, Bradenton, FL, said she began using the PanOptix IOL as soon as it became available and estimates that she had already implanted it in several hundred eyes within the first six months.
“I think PanOptix is the lens we have been waiting for in the United States,” she said. “With the PanOptix, we can actually meet patient expectations for independence from glasses at all distances.”
Dr. McCabe noted that the patients she has implanted with the PanOptix have been very enthusiastic about their outcomes, and they are sharing their experience with family and friends.
“Happy and satisfied patients build the market and practices too,” she said. “Although the PanOptix has been available for a relatively short time, I am already seeing patients asking for it through word-of-mouth referral.”
In Canada, ophthalmologists have had access to the PanOptix IOL for more than three years.
Rosa Braga-Mele, MD, MEd, professor of ophthalmology, University of Toronto, Toronto, Ontario, Canada, has been using the lens since it came onto the market in her country and echoed the idea that the lens has benefits for patients and practices.
“Unless we did some mixing and matching or mini-monovision, traditional multifocal IOLs and extended depth of focus (EDOF) IOLs had a weakness at some focal point,” Dr. Braga-Mele said. “In contrast, the PanOptix IOL delivers a blended range of vision with good vision at distance, intermediate, and near without glasses.”
Dr. Braga-Mele noted that with the toric version, ophthalmologists can correct a good range of astigmatism.
“Appropriate patient selection and education are still critical, but given that is done, patients are very, very satisfied with their outcome,” she said. “Happy patients are a source for more patient referrals.”
Place in practice
Dr. Braga-Mele said that the PanOptix has become her go-to lens for patients wanting presbyopia correction. It is her lens of choice for patients who in the past she would have offered a bifocal multifocal IOL or an EDOF IOL, and she is offering the PanOptix to a broader pool of patients because of its superior range of vision.
Dr. McCabe pointed out that she has years of experience with various multifocal and accommodating presbyopia-correcting lenses, dating back to the days of the ReZoom and first ReSTOR IOLs.
“I have always tried to find the best solution to match each patient’s needs with the fewest side effects,” she said. “PanOptix is the first lens that gives a useable, functional range of vision.”
With the PanOptix IOL, preoperative counseling conversations with patients have changed for the better. Dr. McCabe observed that in the past she spent a lot of time explaining a variety of options to patients.
“I used to have to say that I could provide technology that would give good uncorrected vision at distance and intermediate and functional vision for near,” she said. “Or, I could offer better near vision with excellent distance vision and ‘okay’ intermediate vision.”
As a third choice, Dr. McCabe said she could try to mix and match technologies to achieve a full range of uncorrected vision.
“It’s a different situation now that I can use one lens that predictably gives excellent vision at distance, intermediate, and near,” she said.
Dr. McCabe also pointed out that in her discussion, she no longer has to distinguish between the intermediate and near focal points or offer surgery with different lenses in fellow eyes.
“I tell patients that I have a lens that will allow them to see up close without glasses and that gives them independence from glasses for their distance vision too,” she noted.
Surgical planning is also easier with the PanOptix because it eliminates mixing and matching and adjusting refractive targets. Both Dr. Braga-Mele and Dr. McCabe say they plan for emmetropia bilaterally when using the PanOptix IOL.